No controlled head-to-head clinical trial between the highest doses of the two medicines has been conducted, making fair comparisons hard to conclude
Adicionalmente, la Arcsa autoriz, en 2023, la venta de comprimidos de 3 m g de semaglutida o Rybelsus , que tambin son del mismo fabricante
Still, it is worth understanding for the sake of precision
In addition to prescription medication and doctor consultations, the Rx Path also includes access to the features of Founds Wellness Path, which well discuss in more detail here
Sitagliptin Lixisenatide is a once daily, exenatide-based short-acting GLP-1RA for the treatment of T2DM
15 The potential clinical presentations, diagnosis, and management of FIP are covered in detail in Chapter 33